City

Beijing (1)

Condition

Autoimmune Hemolytic Anemia (1)

Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Peking Union Medical College Hospital (1)

Collaborator

Intervention

combination of a single dose anti-cd20 antibody and bortezomib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

autoimmune hemolytic anemia and autoimmune thrombocytopenia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a

Recruiting

Autoimmune Hemolytic Anemia
Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia

combination of a single dose anti-CD20 antibody and bortezomib

Beijing, Beijing, China

Peking Union Medical College Hospital

Oct 12, 2021